Losartan 25 mg tablet is a generic prescription medicine for oral use, made by 34 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Losartan
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1000 tablets, 90 tablets, 30 tablets and 155 more
- Manufacturers
- Zydus LifesciencesIndiaAlembic PharmaceuticalsIndiaCamber PharmaceuticalsIndiaGranules IndiaIndiaAurobindo PharmaIndiaJubilant Cadista PharmaceuticalsIndiaLupinIndiaMacleods PharmaceuticalsIndia34 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09CA01 Losartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 October 2010
- Identifiers
- RxCUI 979480, 979485, 979492DailyMed set ID c565e7ba-97aa-4a65-80e6-543e9af6e1c4, ee58207e-3913-4262-87ec-930bb4ecf07b, 31366b4b-dfd6-4fda-babe-2cb3d2c14a2b +37NDC 0615-7958, 63629-2426, 65862-201 +37Application ANDA078243, ANDA201170, ANDA090083 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 34 labelers. The register lists 158 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1000 tablet in 1 bottle | 68180-376-03 | LupinIndia | 1 November 2017 |
| 90 tablet in 1 bottle | 68180-376-09 | LupinIndia | 1 November 2017 |
| 30 tablet, film coated in 1 bottle | 46708-445-30 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 100 tablet, film coated in 1 bottle | 46708-445-31 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 90 tablet, film coated in 1 bottle | 46708-445-90 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 1000 tablet, film coated in 1 bottle | 46708-445-91 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 30 tablet, film coated in 1 bottle | 62332-027-30 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 100 tablet, film coated in 1 bottle | 62332-027-31 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 90 tablet, film coated in 1 bottle | 62332-027-90 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 1000 tablet, film coated in 1 bottle | 62332-027-91 | Alembic PharmaceuticalsIndia | 23 May 2016 |
| 1000 tablet in 1 bottle | 62207-741-49 | Granules IndiaIndia | 18 March 2025 |
| 30 tablet in 1 bottle | 62207-741-54 | Granules IndiaIndia | 18 March 2025 |
| 30 tablet in 1 bottle | 70010-741-03 | Granules IndiaIndia | 8 March 2023 |
| 90 tablet in 1 bottle | 70010-741-09 | Granules IndiaIndia | 8 March 2023 |
| 1000 tablet in 1 bottle | 70010-741-10 | Granules IndiaIndia | 8 March 2023 |
| 100 tablet, film coated in 1 bottle | 65841-729-01 | Zydus LifesciencesIndia | 4 October 2010 |
| 30 tablet, film coated in 1 bottle | 65841-729-06 | Zydus LifesciencesIndia | 4 October 2010 |
| 1000 tablet, film coated in 1 bottle | 65841-729-10 | Zydus LifesciencesIndia | 4 October 2010 |
| 90 tablet, film coated in 1 bottle | 65841-729-16 | Zydus LifesciencesIndia | 4 October 2010 |
| 10000 tablet, film coated in 1 bottle | 65841-729-24 | Zydus LifesciencesIndia | 4 October 2010 |
| 100 tablet, film coated in 1 bottle | 68382-135-01 | Zydus LifesciencesIndia | 4 October 2010 |
| 30 tablet, film coated in 1 bottle | 68382-135-06 | Zydus LifesciencesIndia | 4 October 2010 |
| 1000 tablet, film coated in 1 bottle | 68382-135-10 | Zydus LifesciencesIndia | 4 October 2010 |
| 90 tablet, film coated in 1 bottle | 68382-135-16 | Zydus LifesciencesIndia | 4 October 2010 |
| 10000 tablet, film coated in 1 bottle | 68382-135-24 | Zydus LifesciencesIndia | 4 October 2010 |
| 500 tablet, film coated in 1 bottle | 65862-201-05 | Aurobindo PharmaIndia | 6 October 2010 |
| 30 tablet, film coated in 1 bottle | 65862-201-30 | Aurobindo PharmaIndia | 6 March 2019 |
| 90 tablet, film coated in 1 bottle | 65862-201-90 | Aurobindo PharmaIndia | 6 October 2010 |
| 1000 tablet, film coated in 1 bottle | 65862-201-99 | Aurobindo PharmaIndia | 6 October 2010 |
| 500 tablet, film coated in 1 bottle | 31722-700-05 | Camber PharmaceuticalsIndia | 19 August 2015 |
| 1000 tablet, film coated in 1 bottle | 31722-700-10 | Camber PharmaceuticalsIndia | 19 August 2015 |
| 30 tablet, film coated in 1 bottle | 31722-700-30 | Camber PharmaceuticalsIndia | 19 August 2015 |
| 60 tablet, film coated in 1 bottle | 31722-700-60 | Camber PharmaceuticalsIndia | 19 August 2015 |
| 90 tablet, film coated in 1 bottle | 31722-700-90 | Camber PharmaceuticalsIndia | 19 August 2015 |
| 100 tablet in 1 bottle | 59746-333-01 | Jubilant Cadista PharmaceuticalsIndia | 18 September 2012 |
| 1000 tablet in 1 bottle | 59746-333-10 | Jubilant Cadista PharmaceuticalsIndia | 18 September 2012 |
| 30 tablet in 1 bottle | 59746-333-30 | Jubilant Cadista PharmaceuticalsIndia | 18 September 2012 |
| 90 tablet in 1 bottle | 59746-333-90 | Jubilant Cadista PharmaceuticalsIndia | 18 September 2012 |
| 30 tablet, film coated in 1 bottle | 33342-044-07 | Macleods PharmaceuticalsIndia | 10 May 2012 |
| 90 tablet, film coated in 1 bottle | 33342-044-10 | Macleods PharmaceuticalsIndia | 10 May 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 April 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Losartan 25 mg tablet.
Other strengths and forms of Losartan
Clinical summary
Losartan is an angiotensin 2 receptor blocker indicated for treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old, among other approved uses. It is available as tablets and oral suspension. MedsAcross supplies Losartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LosartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- COZAAR prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
Need Losartan 25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.